Topics

People on tofacitinib with low disease activity may be able to safely withdraw methotrexate

02:00 EDT 11 Oct 2019 | Arthritis Digest

Rheumatoid arthritis patients who achieve low disease activity with tofacitinib and methotrexate can safely withdraw methotrexate without fear of worsening disease activity, scientists report in The Lancet Rheumatology. A total of 623 adults with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate were given tofacitinib once a day for 24 weeks plus methotrexate. The […]

The post People on tofacitinib with low disease activity may be able to safely withdraw methotrexate appeared first on Arthritis Digest.

Original Article: People on tofacitinib with low disease activity may be able to safely withdraw methotrexate

NEXT ARTICLE

More From BioPortfolio on "People on tofacitinib with low disease activity may be able to safely withdraw methotrexate"

Quick Search

Relevant Topics

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...